Toxic substances and the nervous system: the role of clinical observation.
D000535:Aluminum / Q000009:adverse effects; D000544:Alzheimer Disease / Q000209:etiology; D001729:Bismuth / Q000009:adverse effects; D001927:Brain Diseases / Q000139:chemically induced; D001929:Brain Edema / Q000139:chemically induced; D004827:Epilepsy / Q000139:chemically induced; D006624:Hippocampus / Q000473:pathology; D006801:Humans; D008767:Methylmercury Compounds / Q000009:adverse effects; D009422:Nervous System Diseases / Q000139:chemically induced*; D009454:Neurofibrils / Q000473:pathology; D009942:Organometallic Compounds / Q000009:adverse effects; D009947:Organotin Compounds / Q000009:adverse effects; D010292:Paresthesia / Q000139:chemically induced; D006435:Renal Dialysis / Q000009:adverse effects; D013756:Tetraethyl Lead / Q000009:adverse effects
D008767:Methylmercury Compounds; D009942:Organometallic Compounds; D009947:Organotin Compounds; D013756:Tetraethyl Lead; D000535:Aluminum; D001729:Bismuth